Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

There are 3 platforms. Two, Brilacidin and Kevetrin, are arguably each worth more than $5 in a buyout, at the present time. We've already seen evidence of each IBD indication exceeding a billion each. $10 billion would be a minimum in a buyout, even at the current stage. Just because a flawed market doesn't reflect that doesn't mean it's not the case.